SynthesisBMJ open diabetes research & care2026
Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes, a systematic review.
Guillaume Grenet et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.